Repros Therapeuticsadmin2022-01-16T21:09:46+00:00 Project Description Confidentially Marketed Public Offering Common Stock and Warrants $3,000,000 Sole Book-Runner May 2017 Related Project Details Categories: Healthcare Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail Related Projects